Silver Book Fact

Opioids have been found to reduce pain intensity and improve physical functioning for patients with persistent noncancer pain. It’s important to note that a decrease in mental health functioning was also seen.

Papaleontiou M, Henderson C, Turner B, Moore A, et al. Outcomes Associated with Opioid Use in the Treatmetn of Chronic Noncacner Pain in Older Adults: A systematic reveiw and meta-analysis. J Am Geriatr Soc. 2010; 58(7): 1353-69. http://onlinelibrary.wiley.com/doi/10.1111/j.1532-5415.2010.02920.x/abstract

Reference

Title
Outcomes Associated with Opioid Use in the Treatmetn of Chronic Noncacner Pain in Older Adults: A systematic reveiw and meta-analysis
Publication
J Am Geriatr Soc
Publication Date
2010
Authors
Papaleontiou M, Henderson C, Turner B, Moore A, et al.
Volume & Issue
Volume 58, Issue 7
Pages
1353-69
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • The use of sodium oxybate (SXB) in fibromylagia patients reduced pain by 30% or more in 54-58% of patients (versus 35.2% for placebo). SXB also reduced fatigue and sleep disturbance.  
  • Nerve growth factor (NGF) has been found to be a major mediator of inflammatory and neuropathic pain and provides a new therapeutic target.  
  • Subthalamic nuclei deep brain stimulation (STN-DBS) raises pain thresholds in Parkinson’s disease patients.  
  • An opiate agonist often used for persistent pain, tramadol was found in one meta-analysis to significantly reduce neuropathic pain when compared to placebo.  
  • An oral cannabinoid was found effective in relieving diabetic peripheral neuropathic pain symptoms and improving disturbed sleep, quality of life, and overall patient status.